Cite
MLA Citation
Elisa Pose et al.. “Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial.” Lancet gastroenterology and hepatology, vol. 5, 2020, pp. 31–41. http://access.bl.uk/ark:/81055/vdc_100098053110.0x000005